pharmaphorum November 30, 2023
Phil Taylor

FDA chief scientist Namandjé Bumpus has been named as principal deputy commissioner, replacing long-serving Janet Woodcock when she steps down early next year.

Bumpus is heading for the number two position at the FDA – second only to Commissioner Robert Califf, who announced the appointment on X (formerly Twitter) – just over a year after she joined the agency.

“As principal deputy commissioner, Namandjé will work closely with FDA leadership to develop, advance, and implement key public health initiatives, as well as to oversee the agency’s day-to-day functions,” said Califf in an email to staff.

“Chief among those priorities is the proposed reorganisation unifying the Human Foods Programme, creating a new model for the Office of Regulatory Affairs, and strengthening...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: FDA, Govt Agencies
FDA issues flu vaccine recommendations: 5 respiratory updates
5 Digital Health Areas To Be Impacted By The FDA Layoffs
FDA Approves First Biosimilar to Omalizumab
Trump's Nominees to Run FDA, NIH Get Greenlighted by Senate Committee
FDA Debuts a New Communications and Compliance Tool for Device Data Integrity Concerns

Share This Article